Trial Profile
Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2018
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Acronyms CONTROL-2
- Sponsors Servier
- 09 Mar 2018 New trial record
- 05 Mar 2018 Primary endpoin (Change in heart rate during the 16-week treatment period)t has been met as per the results published in the Advances in Therapy
- 05 Mar 2018 Primary endpoint (Number of angina attacks with standard therapy vs ivabradine) has been met as per the results published in the Advances in Therapy